BioVie Inc. Earnings Per Share (Basic)
BioVie Inc. (BIVI) reported Earnings Per Share (Basic) of -$3.05 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- BioVie Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.70.
- BioVie Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.77.
- BioVie Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.98.
- BioVie Inc. earnings per share, basic for the quarter ending 2025-03-31 was -$1.51.
- BioVie Inc. earnings per share, basic for fiscal 2026 was -$3.05.
- BioVie Inc. earnings per share, basic for fiscal 2025 was -$12.12.
- BioVie Inc. earnings per share, basic for fiscal 2023 was -$15.47.
- BioVie Inc. earnings per share, basic for fiscal 2022 was -$1.06.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.05 10-K · filed 2026-08-13 | |||||||
| 2026-03-31 | -$0.70 S-1/A · filed 2026-08-06 | -$2.35 S-1/A · filed 2026-08-06 | ||||||
| 2025-12-31 | -$0.77 10-Q · filed 2026-02-06 | -$1.70 10-Q · filed 2026-02-06 | ||||||
| 2025-09-30 | -$0.98 10-Q · filed 2025-11-10 | |||||||
| 2025-06-30 | -$12.12 10-K · filed 2026-08-13 | |||||||
| 2025-03-31 | -$1.51 S-1/A · filed 2026-08-06 | -$0.15 10-Q · filed 2025-05-12 | -$10.68 S-1/A · filed 2026-08-06 | -$1.07 10-Q · filed 2025-05-12 | ||||
| 2024-12-31 | -$4.55 10-Q · filed 2026-02-06 | -$0.46 10-Q · filed 2025-02-11 | -$10.54 10-Q · filed 2026-02-06 | -$1.05 10-Q · filed 2025-02-11 | ||||
| 2024-09-30 | -$7.00 10-Q · filed 2025-11-10 | -$0.70 10-Q · filed 2024-11-13 | ||||||
| 2024-06-30 | $0.49 derived: net income ÷ weighted average shares · filed 2026-08-06 | $4.90 derived: net income ÷ weighted average shares · filed 2026-08-06 | $36.03 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$73.05 S-1/A · filed 2026-08-06 | -$7.30 10-K · filed 2024-09-30 | |||
| 2024-03-31 | -$2.00 10-Q · filed 2025-05-12 | -$0.20 10-Q · filed 2024-05-14 | -$4.18 derived: net income ÷ weighted average shares · filed 2025-05-12 | -$7.04 10-Q · filed 2025-05-12 | -$0.70 10-Q · filed 2024-05-14 | $2.17 derived: net income ÷ weighted average shares · filed 2025-05-12 | ||
| 2023-12-31 | -$2.20 10-Q · filed 2025-02-11 | -$0.22 10-Q · filed 2024-02-13 | -$5.10 10-Q · filed 2025-02-11 | -$0.51 10-Q · filed 2024-02-13 | $1.16 derived: net income ÷ weighted average shares · filed 2025-02-11 | $4.57 derived: net income ÷ weighted average shares · filed 2025-02-11 | ||
| 2023-09-30 | -$2.92 10-Q · filed 2024-11-13 | -$0.29 10-Q · filed 2023-11-08 | $0.51 derived: net income ÷ weighted average shares · filed 2024-11-13 | $2.51 derived: net income ÷ weighted average shares · filed 2024-11-13 | $19.27 derived: net income ÷ weighted average shares · filed 2024-11-13 | |||
| 2023-06-30 | $0.11 derived: net income ÷ weighted average shares · filed 2024-09-30 | $1.07 derived: net income ÷ weighted average shares · filed 2024-09-30 | $8.44 derived: net income ÷ weighted average shares · filed 2024-09-30 | -$15.47 10-K · filed 2024-09-30 | -$1.55 10-K · filed 2023-08-16 | |||
| 2023-03-31 | -$0.43 10-Q · filed 2024-05-14 | -$0.92 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.32 10-Q · filed 2024-05-14 | -$1.66 derived: net income ÷ weighted average shares · filed 2024-05-14 | ||||
| 2022-12-31 | -$0.50 10-Q · filed 2024-02-13 | -$0.89 10-Q · filed 2024-02-13 | -$1.23 derived: net income ÷ weighted average shares · filed 2024-02-13 | -$1.52 derived: net income ÷ weighted average shares · filed 2024-02-13 | ||||
| 2022-09-30 | -$0.38 10-Q · filed 2023-11-08 | -$0.71 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-11-08 | |||||
| 2022-06-30 | -$0.32 derived: net income ÷ weighted average shares · filed 2023-08-16 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-08-16 | -$1.06 10-K · filed 2023-08-16 | |||||
| 2022-03-31 | -$0.28 10-Q · filed 2023-05-12 | -$0.73 10-Q · filed 2023-05-12 | ||||||
| 2021-12-31 | -$0.22 10-Q · filed 2023-02-10 | -$0.45 10-Q · filed 2023-02-10 | ||||||
| 2021-09-30 | -$0.23 10-Q · filed 2022-11-04 | |||||||
| 2021-06-30 | -$14.82 10-K · filed 2022-09-27 | |||||||
| 2021-03-31 | -$0.22 10-Q · filed 2022-05-11 | -$4.64 10-Q · filed 2022-05-11 | ||||||
| 2020-12-31 | -$0.22 10-Q · filed 2022-02-08 | -$4.95 10-Q · filed 2022-02-08 | ||||||
| 2020-09-30 | -$7.75 10-Q · filed 2021-11-10 | |||||||
| 2020-06-30 | -$6.85 10-K · filed 2021-08-30 | |||||||
| 2020-03-31 | -$0.07 10-Q · filed 2021-05-10 | -$3.02 10-Q · filed 2021-05-10 | ||||||
| 2019-12-31 | $1.29 10-Q · filed 2021-01-29 | -$3.06 10-Q · filed 2021-01-29 | ||||||
| 2019-09-30 | -$5.06 10-Q · filed 2020-11-05 | |||||||
| 2019-06-30 | -$0.98 10-K/A · filed 2020-08-07 | |||||||
| 2019-03-31 | -$0.34 10-Q · filed 2020-05-13 | -$0.73 10-Q · filed 2020-05-13 | ||||||
| 2018-12-31 | -$0.20 10-Q · filed 2020-02-13 | -$0.40 10-Q · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |